Initial viral load determines the magnitude of the human CD8 T cell response to yellow fever vaccination
暂无分享,去创建一个
Rustom Antia | Helder I. Nakaya | Bali Pulendran | B. Pulendran | Philip L. F. Johnson | H. Nakaya | R. Ahmed | Rama S. Akondy | M. Mulligan | R. Antia | S. Edupuganti | Joseph D. Miller | Rafi Ahmed | Srilatha Edupuganti | Mark J. Mulligan | Benton Lawson | B. Lawson | Srilatha Edupuganti
[1] G. Shaw,et al. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection , 1994, Journal of virology.
[2] Alan S. Perelson,et al. Kinetics of Virus-Specific CD8+ T Cells and the Control of Human Immunodeficiency Virus Infection , 2004, Journal of Virology.
[3] Eric G. Pamer,et al. Early Programming of T Cell Populations Responding to Bacterial Infection1 , 2000, The Journal of Immunology.
[4] T. Ndung’u,et al. Association between Virus-Specific T-Cell Responses and Plasma Viral Load in Human Immunodeficiency Virus Type 1 Subtype C Infection , 2003, Journal of Virology.
[5] Matthew S. Lewis,et al. Immune clearance of highly pathogenic SIV infection , 2013, Nature.
[6] B. Gärtner,et al. Dominance of virus-specific CD8 T cells in human primary cytomegalovirus infection. , 2002, Journal of the American Society of Nephrology : JASN.
[7] Terri Wrin,et al. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. , 2008, The Journal of infectious diseases.
[8] E. James,et al. Yellow Fever Vaccination Elicits Broad Functional CD4+ T Cell Responses That Recognize Structural and Nonstructural Proteins , 2013, Journal of Virology.
[9] J. Borovička,et al. Polyfunctional HCV‐specific T‐cell responses are associated with effective control of HCV replication , 2008, European journal of immunology.
[10] Bastian R. Angermann,et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses , 2008, The Journal of experimental medicine.
[11] Mario Roederer,et al. CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates , 2011, Nature Medicine.
[12] W. Paul,et al. Magnitude of response of histocompatibility-restricted T-cell clones is a function of the product of the concentrations of antigen and Ia molecules. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[13] M. Cetron,et al. A randomized, double-blind, controlled trial of the 17D yellow fever virus vaccine given in combination with immune globulin or placebo: comparative viremia and immunogenicity. , 2013, The American journal of tropical medicine and hygiene.
[14] Eva K. Lee,et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans , 2009, Nature Immunology.
[15] David Heckerman,et al. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load , 2007, Nature Medicine.
[16] Mario Roederer,et al. Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge , 2014, Nature Medicine.
[17] Susan M. Kaech,et al. Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naïve cells , 2001, Nature Immunology.
[18] R. Koup,et al. Analysis of Total Human Immunodeficiency Virus (HIV)-Specific CD4+ and CD8+ T-Cell Responses: Relationship to Viral Load in Untreated HIV Infection , 2001, Journal of Virology.
[19] J. Altman,et al. Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. , 2008, Immunity.
[20] M. Cetron,et al. Case of yellow fever vaccine--associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes. , 2008, The Journal of infectious diseases.
[21] R. Webby,et al. Dynamic T cell migration program provides resident memory within intestinal epithelium , 2010, The Journal of experimental medicine.
[22] Becca Asquith,et al. The Efficiency of the Human CD8+ T Cell Response: How Should We Quantify It, What Determines It, and Does It Matter? , 2012, PLoS Comput. Biol..
[23] Lyric C. Bartholomay,et al. Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria , 2008, Proceedings of the National Academy of Sciences.
[24] Persephone Borrow,et al. Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIV , 1994, Nature.
[25] Helder I Nakaya,et al. Immunity to viruses: learning from successful human vaccines , 2013, Immunological reviews.
[26] Adeeba Kamarulzaman,et al. AIDS Res Hum Retroviruses , 2006 .
[27] P. Klenerman,et al. Ever closer to a prophylactic vaccine for HCV , 2013, Expert opinion on biological therapy.
[28] Lei Zhang,et al. Understanding the mechanisms and limitations of immune control of HIV , 2007, Immunological reviews.
[29] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[30] D. Ho,et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome , 1994, Journal of virology.
[31] B. Walker,et al. Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection. , 1996, AIDS research and human retroviruses.
[32] T. Monath,et al. Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine. , 1981, Bulletin of the World Health Organization.
[33] Charles G. Drake,et al. Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer , 2014, Nature Reviews Clinical Oncology.
[34] B. Walker,et al. Proliferative Capacity of Epitope-Specific CD8 T-Cell Responses Is Inversely Related to Viral Load in Chronic Human Immunodeficiency Virus Type 1 Infection , 2006, Journal of Virology.
[35] B. P. Lienko. [Yellow fever (epidemiology and prevention)]. , 1983, Meditsinskaia sestra.
[36] Devan V Mehrotra,et al. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial , 2008, The Lancet.
[37] A. Perelson,et al. High-Potency Human Immunodeficiency Virus Vaccination Leads to Delayed and Reduced CD8+ T-Cell Expansion but Improved Virus Control , 2005, Journal of Virology.
[38] Jerome H. Kim,et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. , 2009, The New England journal of medicine.
[39] M. Nowak,et al. Population Dynamics of Immune Responses to Persistent Viruses , 1996, Science.
[40] C. Rice,et al. Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes , 2005, The Journal of experimental medicine.
[41] A. Kamphorst,et al. Manipulating the PD-1 pathway to improve immunity. , 2013, Current opinion in immunology.
[42] K. Stiasny,et al. Dissection of Antibody Specificities Induced by Yellow Fever Vaccination , 2013, PLoS pathogens.
[43] William R. Jacobs,et al. A Critical Role for CD8 T Cells in a Nonhuman Primate Model of Tuberculosis , 2009, PLoS pathogens.
[44] Stephen P. Schoenberger,et al. Naïve CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation , 2001, Nature Immunology.
[45] Matthew S. Lewis,et al. Profound early control of highly pathogenic SIV by an effector-memory T cell vaccine , 2011, Nature.
[46] J. Altman,et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. , 1998, Immunity.
[47] B. Asquith,et al. Quantifying HTLV‐I dynamics , 2007, Immunology and cell biology.
[48] S. Kaech,et al. Generation of effector CD8+ T cells and their conversion to memory T cells , 2010, Immunological reviews.
[49] Carl T. Bergstrom,et al. Models of CD8+ responses: 1. What is the antigen-independent proliferation program. , 2003, Journal of theoretical biology.
[50] C. Rice,et al. The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response1 , 2009, The Journal of Immunology.